Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.

Source:http://linkedlifedata.com/resource/pubmed/id/7962541

Download in:

View as

General Info

PMID
7962541